Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

OBJECTIVE: We evaluated the activity and safety of the combination of topotecan, cisplatin and bevacizumab in patients with recurrent or persistent carcinoma of the cervix. METHODS: Eligible patients had persistent or recurrent cervical cancer not amenable to curative intent treatment. No prior chem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zighelboim, Israel, Wright, Jason D., Gao, Feng, Case, Ashley S., Massad, L. Stewart, Mutch, David G., Powell, Matthew A., Thaker, Premal H., Eisenhauer, Eric L., Cohn, David E., Valea, Fidel A., Secord, Angeles Alvarez, Lippmann, Lynne T., Dehdashti, Farrokh, Rader, Janet S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870479/
https://ncbi.nlm.nih.gov/pubmed/23591400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.04.009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge